InvestorsHub Logo
Followers 60
Posts 2078
Boards Moderated 0
Alias Born 03/27/2011

Re: Toxic Avenger post# 246

Wednesday, 06/15/2016 1:35:27 PM

Wednesday, June 15, 2016 1:35:27 PM

Post# of 431
I keep seeing people saying "we only get 19%". Not true we as a stockholder own stock in the combined assets of the deal. the 19 vs 81% is that the insiders of Kalvista will own 81% of the outstanding shares. just like you own a certain % of shares. Now this probably means that the OS will go up to allow for Kalvista insiders to obtain 81%, but as insiders it isn't a big deal as they aren't going to sell them off anytime soon.


from 8k

On June 15, 2016, Carbylan Therapeutics, Inc. (“Carbylan”), KalVista Pharmaceuticals Ltd., a private company limited by shares incorporated and registered in England and Wales (“Kalvista”), the shareholders of KalVista (each a “Seller” and collectively, the “Sellers”)

The Sellers own 100% of the outstanding KalVista Shares and following the consummation of the Transaction, KalVista will become a wholly owned subsidiary of Carbylan.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KALV News